Ron Waksman

Lipid-rich plaque density and low-density lipoprotein cholesterol in statin-treated versus statin-naïve patients: a post hoc analysis of the LRP study

Torguson R, Mintz G, Zhang C, Case B, Di Mario C, Garcia-Garcia H, Waksman R

May 15, 2022 | 10.4244/EIJ-D-21-00701

Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study

Medranda GA, Soria Jimenez CE, Torguson R, Case B, Forrestal BJ, Ali SW, Shea C, Zhang C, Wang JC, Gordon P, Ehsan A, Wilson SR, Levitt R, Parikh P, Bilfinger T, Hanna N, Buchbinder M, Asch FM, Weissman G, Shults CC, Garcia-Garcia H, Ben-Dor I, Satler LF, Waksman R, Rogers T

March 25, 2022 | 10.4244/EIJ-D-21-01091

Scaffold thrombosis: what is to blame?

Waksman R, Bhogal S

December 17, 2021 | 10.4244/EIJV17I12A159

A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE)

Räber L, Häner J, Lüscher T, Moccetti M, Roffi M, Stortecky S, Muller O, Garcia-Garcia H, Waksman R, Siegrist P

November 11, 2021 | 10.4244/EIJ-D-21-00537

High bleeding risk patients: one size does not fit all

Waksman R, Yerasi C

June 25, 2021 | 10.4244/EIJV17I3A35

Entrapment of the Impella heart pump in the mitral subvalvular apparatus

Khalid N, Shlofmitz E, Case B, Waksman R

February 5, 2021 | 10.4244/EIJ-D-19-00942

Adverse events with orbital atherectomy: an analytic review of the MAUDE database

Khalid N, Javed H, Rogers T, Hashim H, Shlofmitz E, Wermers J, Chen Y, Musallam A, Khan J, Torguson R, Bernardo N, Waksman R

July 17, 2020 | 10.4244/EIJ-D-19-00295

Bioresorbable scaffolds: did we jump the gun?

Waksman R, Forrestal B

June 12, 2020 | 10.4244/EIJV16I2A16

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Reply to the letter to the editor “Impella device use in high-risk PCI”

Khalid N, Rogers T, Shlofmitz E, Chen Y, Waksman R

October 18, 2019 | 10.4244/EIJ-D-19-00279R

Paclitaxel-coated balloons and stents for the treatment of peripheral artery disease: proceedings from the Cardiovascular Research Technologies (CRT) 2019 Town Hall

Dan K, Garcia-Garcia H, Hideo-Kajita A, Zhang C, Wermers J, Kolm P, Torguson R, Waksman R

July 19, 2019 | 10.4244/EIJV15I4A59

Paclitaxel-coated balloons and stents for the treatment of peripheral artery disease: proceedings from the Cardiovascular Research Technologies (CRT) 2019 Town Hall

Dan K, Garcia-Garcia H, Hideo-Kajita A, Zhang C, Wermers J, Kolm P, Torguson R, Waksman R

June 13, 2019 | 10.4244/EIJY19M06_1

Adverse events and modes of failure related to the Impella percutaneous left ventricular assist devices: a retrospective analysis of the MAUDE database

Khalid N, Rogers T, Shlofmitz E, Chen Y, Khan J, Musallam A, Iantorno M, Waksman R

May 20, 2019 | 10.4244/EIJ-D-18-01021

Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model

Lipinski M, Acampado E, Cheng Q, Adams L, Torii S, Gai J, Torguson R, Hellinga DG, Joner M, Harder C, Zumstein P, Finn A, Kolodgie F, Virmani R, Waksman R

January 18, 2019 | 10.4244/EIJ-D-17-00958

Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds

Joner M, Ruppelt P, Zumstein P, Lapointe-Corriveau C, Leclerc G, Bulin A, Castellanos M, Wittchow E, Haude M, Waksman R

October 12, 2018 | 10.4244/EIJ-D-17-00708

Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III

Haude M, Ince H, Kische S, Abizaid A, Toelg R, Lemos P, Van Mieghem N, Verheye S, von Birgelen C, Christiansen E, Wijns W, Garcia-Garcia H, Waksman R

July 20, 2017 | 10.4244/EIJ-D-17-00254

Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model

Waksman R, Zumstein P, Pritsch M, Wittchow E, Haude M, Lapointe-Corriveau C, Leclerc G, Joner M

July 20, 2017 | 10.4244/EIJ-D-16-00915

Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold?

Sotomi Y, Miyazaki Y, Collet C, Asano T, Suwannasom P, Thijssen J, de Winter R, Waksman R, Lipinski M, Onuma Y, Serruys P

March 20, 2017 | 10.4244/EIJ-D-16-00472

Chipping of calcified plaques by orbital atherectomy systems, but holding approval tight: is the FDA moving faster than the European CE agency? A North American perspective

Waksman R, Garcia-Garcia H

October 20, 2016 | 10.4244/EIJV12I9A178

Ron Waksman

Latest news